These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 32266979)
1. Secondary bladder and rectal cancer risk estimates following standard fractionated and moderately hypofractionated VMAT for prostate carcinoma. Mazonakis M; Kachris S; Damilakis J Med Phys; 2020 Jul; 47(7):2805-2813. PubMed ID: 32266979 [TBL] [Abstract][Full Text] [Related]
2. Risk for second bladder and rectal malignancies from cervical cancer irradiation. Mazonakis M; Lyraraki E; Tolia M; Damilakis J J Appl Clin Med Phys; 2021 Jul; 22(7):103-109. PubMed ID: 34021692 [TBL] [Abstract][Full Text] [Related]
3. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy. Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229 [TBL] [Abstract][Full Text] [Related]
5. Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes. Zwahlen DR; Bischoff LI; Gruber G; Sumila M; Schneider U Radiat Oncol; 2016 Nov; 11(1):149. PubMed ID: 27832799 [TBL] [Abstract][Full Text] [Related]
6. Comparison of dose statistics for bladder wall and rectum wall vs whole organs for VMAT prostate treatment. Desrochers A; Ghosh S; Parliament M; Garraway R; Kellogg L; Larocque MP Med Dosim; 2020 Summer; 45(2):140-148. PubMed ID: 31562018 [TBL] [Abstract][Full Text] [Related]
7. Variations in dosimetric distribution and plan complexity with collimator angles in hypofractionated volumetric arc radiotherapy for treating prostate cancer. Li MH; Huang SF; Chang CC; Lin JC; Tsai JT J Appl Clin Med Phys; 2018 Mar; 19(2):93-102. PubMed ID: 29322625 [TBL] [Abstract][Full Text] [Related]
8. Risk of contralateral breast and ipsilateral lung cancer induction from forward-planned IMRT for breast carcinoma. Mazonakis M; Stratakis J; Lyraraki E; Damilakis J Phys Med; 2019 Apr; 60():44-49. PubMed ID: 31000085 [TBL] [Abstract][Full Text] [Related]
9. VMAT for prostate cancer with 6-MV and 10-MV photons: Impact of beam energy on treatment plan quality and model-based secondary cancer risk estimates. Mazonakis M; Kachris S; Damilakis J Mol Clin Oncol; 2021 May; 14(5):89. PubMed ID: 33767858 [TBL] [Abstract][Full Text] [Related]
10. A Dosimetric Comparison between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer. Li M; Li GF; Hou XY; Gao H; Xu YG; Zhao T Chin Med J (Engl); 2016 Jun; 129(12):1447-54. PubMed ID: 27270540 [TBL] [Abstract][Full Text] [Related]
11. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study. Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271 [TBL] [Abstract][Full Text] [Related]
12. Dose painting to treat single-lobe prostate cancer with hypofractionated high-dose radiation using targeted external beam radiation: Is it feasible? Amini A; Westerly DC; Waxweiler TV; Ryan N; Raben D Med Dosim; 2015; 40(3):256-61. PubMed ID: 25824420 [TBL] [Abstract][Full Text] [Related]
13. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy. Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189 [TBL] [Abstract][Full Text] [Related]
14. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy. Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369 [TBL] [Abstract][Full Text] [Related]
15. Adaptive radiation therapy strategies in the treatment of prostate cancer patients using hypofractionated VMAT. Siciarz P; McCurdy B; Hanumanthappa N; Van Uytven E J Appl Clin Med Phys; 2021 Dec; 22(12):7-26. PubMed ID: 34787360 [TBL] [Abstract][Full Text] [Related]
16. Late toxicity in the randomized multicenter HYPRO trial for prostate cancer analyzed with automated treatment planning. Sharfo AWM; Dirkx MLP; Bijman RG; Schillemans W; Breedveld S; Aluwini S; Pos F; Incrocci L; Heijmen BJM Radiother Oncol; 2018 Aug; 128(2):349-356. PubMed ID: 29885745 [TBL] [Abstract][Full Text] [Related]
17. Lifetime radiation-induced sarcoma risk in patients subjected to IMRT or VMAT for uterine cervix carcinoma. Mazonakis M; Lyraraki E; Damilakis J Phys Eng Sci Med; 2021 Jun; 44(2):573-579. PubMed ID: 33909230 [TBL] [Abstract][Full Text] [Related]
18. Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation. Haciislamoglu E; Gungor G; Aydin G; Canyilmaz E; Guler OC; Zengin AY; Yenice KM J Appl Clin Med Phys; 2020 Sep; 21(9):82-89. PubMed ID: 32671989 [TBL] [Abstract][Full Text] [Related]
19. Maximizing rectal dose sparing with hydrogel: A retrospective planning study. Paetkau O; Gagne IM; Pai HH; Lam J; Goulart J; Alexander A J Appl Clin Med Phys; 2019 Apr; 20(4):91-98. PubMed ID: 30889318 [TBL] [Abstract][Full Text] [Related]
20. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample. Kopp RW; Duff M; Catalfamo F; Shah D; Rajecki M; Ahmad K Med Dosim; 2011; 36(4):365-72. PubMed ID: 21377863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]